诚意药业：控股股东及其一致行动人合计持股比例降至24%

Core Viewpoint - The controlling shareholder of Chengyi Pharmaceutical, Yan Yiyi, and his concerted parties have reduced their shareholding from 24.77% to 24% as of the announcement date [1] Shareholding Changes - Yan Xiaoling reduced her holdings by 349,722 shares through centralized bidding on October 30, 2025 [1] - Wenzhou Dongtou Chengyi Microfinance Co., Ltd. reduced its holdings by 2,164,900 shares through centralized bidding and block trading from November 7 to 14, 2025 [1] - The total reduction amounts to 2,514,622 shares, representing 0.77% of the total share capital [1] Impact on Control and Operations - This change in equity is part of a planned reduction and does not lead to a change in the actual controller [1] - The reduction will not affect the company's operations [1]